Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.
-
The Future of Intelligent Vehicle Interiors: Building Trust With HMI & AI – Ep. 194
Imagine a future where your vehicle’s interior offers personalized experiences and builds trust through human-machine interfaces and artificial intelligence. In this episode of the NVIDIA AI Podcast, host Katie Burke Washabaugh and guest Andreas Binner,…
-
How GlüxKind Created Ella, the AI-Powered Smart Stroller – Ep. 193
Imagine a stroller that can drive itself, help users up hills, brake on slopes and provide alerts of potential hazards. That’s what GlüxKind has done with Ella, an award-winning smart stroller that uses the NVIDIA…
-
Ubisoft’s Yves Jacquier on How Generative AI Will Revolutionize Gaming – Ep. 192
Tools like ChatGPT have awakened the world to the potential of generative AI. Now, much more is coming. On the latest episode of NVIDIA’s AI Podcast, Yves Jacquier, executive director of Ubisoft La Forge, shares…
-
Peter Ma on Using AI to Find Promising Signals for Alien Life – Ep. 191
Peter Ma was bored in his high school computer science class. So he decided to teach himself something new: how to use artificial intelligence to find alien life. That’s how he eventually became the lead…
-
Glean Founders Talk AI-Powered Enterprise Search on NVIDIA Podcast – Ep. 190
In the quest for knowledge at work, it can be tempting to think that finding what you need is like a needle in a haystack. But what if the haystack itself could show you where…